Purchase Order 75N93020P01393
- Not listed
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Washington School of Medicine. The $23,012,457.00 firm-fixed-price contract is for specialized biomedical services and laboratory testing to support federal healthcare and research initiatives. The School of Medicine, which is a part of the University of Washington, has extensive expertise in clinical pathology,...
- The University of Washington, a public research university in Seattle, Washington, was awarded a $7,923,187.00 definitive contract from the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases. The contract, which does not have a set-aside designation, is for biomedical (basic) services with a completion date of April 30, 2008. The University of Washington has a long history of providing specialized laboratory testing,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases has awarded a $249,900.00 firm fixed price purchase order contract to the University of Washington School of Medicine for laboratory testing services in support of a malaria study in Mali. The contract has a completion date of January 4, 2024. The University of Washington School of Medicine is the prime contractor and is a U.S. state government entity. No set-aside...
- The University of Washington (UW) was awarded a $9,170,967.00 definitive contract from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), for "POPULATION GENETICS ANALYSIS PROGRAMS: IMMUNITY TO VACCINES". The contract, which does not have a set-aside designation, was awarded on September 30, 2004 and has an ultimate completion date of November 19, 2013. UW is a leading public research university that leverages...
- This delivery order award of $50,000 to the University of Washington (UW) was made under the National Institute of Allergy and Infectious Diseases (NIAID) Animal Models of Infectious Diseases 2010-2017 indefinite delivery contract. The award is for animal models of infectious diseases research and does not have a set-aside designation. UW is a leading research university that has received numerous federal contract and grant awards across various disciplines, often acting as both a prime...
- The University of Washington (UW) was awarded a $6,239,075 definitive cost-no-fee contract by the National Institute of Allergy and Infectious Diseases (NIAID) to conduct research on "Immune Function and Biodefense in Children, Elderly and Immunocompromised Populations." The contract has an ultimate completion date of September 30, 2011 and does not have a set-aside designation. UW, a leading public research university, is leveraging its extensive expertise in healthcare, research, and...
- The University of Washington (UW) was awarded a $23,929.92 firm fixed-price purchase order contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for the collection of 8 lymph node samples under the AMBIS 1698527 LYMPH NODE COLLECTION (ACTU 098) project. This contract does not have a set-aside designation. UW, a leading public research university, frequently secures prime contracts, grants, and subcontracts from both...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the University of Washington (UW) to provide QRT-PCR testing analysis services. The contract has a ceiling value of $194,400.00 and a period of performance ending August 18, 2025. The contract does not have a set-aside designation. UW is a leading research university that has received numerous prime federal contract and grant awards to support a...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to University of Washington for $27,123.38 on May 6, 2016, for the Lymph Node Project, with final completion on May 9, 2017. Work is performed in Seattle, Washington. The order is a firm fixed price purchase order with no small business set-aside.</p>
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $196,668.00 firm fixed price purchase order to the University of Washington (UW) for Quantitative Reverse Transcription Polymerase Chain Reaction (QRT-PCR) testing analysis services. The contract has an ultimate completion date of December 31, 2025 and was awarded on January 1, 2025 with no set-aside designation. UW is a leading research university that has received numerous prime federal contract and grant awards to...
This federal contract award, valued at $32,396.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to the University of Washington School of Medicine, doing business as the University of Washington Department of Laboratory Medicine. The contract, which is a firm-fixed price purchase order, is for Immunoplex Sequencing services. The award was made on a sole-source basis, as NIAID determined that the University of Washington was the only responsible source that could provide the required services. The University of Washington is the parent organization of the School of Medicine, and both entities have extensive experience in supporting federal healthcare and research initiatives through contracts and grants. This contract award is not associated with any set-aside program.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
IMMUNOPLEX SEQUENCING | NOI-RML-E-2033943 | Department of Health and Human Services National Institutes of Health | Solicitation 1/1 | 8/18/20, 5:42 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.4k | 9/22/20 |